Improvement of the Immunochromatographic NG-Test Carba 5 Assay for the Detection of IMP Variants Previously Undetected
- Authors
- Type
- Published Article
- Journal
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Publication Date
- Dec 20, 2019
- Volume
- 64
- Issue
- 1
- Identifiers
- DOI: 10.1128/AAC.01940-19
- PMID: 31685459
- PMCID: PMC7187612
- Source
- PubMed Central
- Keywords
- License
- Unknown
Abstract
Here, we evaluated the immunochromatographic assay NG-Test Carba 5v2 (NG-Biotech), with improved IMP variant detection on 31 IMP producers, representing the different branches of the IMP phylogeny, including 32 OXA-48, 19 KPC, 12 VIM, 14 NDM, and 13 multiple carbapenemase producers (CPs), 13 CPs that were not targeted, and 13 carbapenemase-negative isolates. All tested IMP variants were accurately detected without impairing detection of the other carbapenemases. Thus, NG-Test Carba 5v2 is now well adapted to countries with high IMP prevalence and to the epidemiology of CP- Pseudomonas aeruginosa , where IMPs are most frequently detected.